VVP
MEDP icon

Venture Visionary Partners’s Medpace MEDP Stock Holding History

Venture Visionary Partners’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-96
Closed -$14.4K – 1114
2022
Q2 		$14.4K Buy
+96
New +$13.9K ﹤0.01% 1125

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
ESCM
Echo Street Capital Management New York $747M AUM 24.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Venture Visionary Partners's MEDP Position: Q3 2022 in Review

Venture Visionary Partners sold out of Medpace (MEDP) in Q3 2022, closing a stake of 96 shares — an estimated $14.4K sold.

Venture Visionary Partners first reported a position in MEDP in Q2 2022 and held it in 1 quarter. The position peaked at $14.4K in Q2 2022. 357 funds tracked by Wall St. Rank hold MEDP as of Q3 2022.

  • Venture Visionary Partners reported no remaining Medpace position as of Q3 2022 after selling out during the quarter.
  • Venture Visionary Partners sold 96 Medpace shares in Q3 2022, an estimated $14.4K.
  • Venture Visionary Partners first reported a position in Medpace in Q2 2022 and held it in 1 quarter.
  • Venture Visionary Partners's Medpace position peaked at $14.4K in Q2 2022.
  • 357 funds tracked by Wall St. Rank held Medpace as of Q3 2022.

Based on Venture Visionary Partners's 13F filing for Q3 2022, filed 14 Nov 2022.